Prebiotics and Probiotics in Infant Formulae - Prebiotics and Probiotics Ingredients - page 334

179. Sazawal, S. et al. Efficacy of probiotics in prevention of acute diarrhoea: A meta-analy-
sis of masked, randomised, placebo-controlled trials. Lancet Inf Dis ., 6, 374, 2006.
180. Schanler, R.J. Probiotics and necrotising enterocolitis in premature infants. Arch Dis
Child Fetal Neonatal Ed ., 91, F395, 2006.
181. Deshpande, G., Rao, S., and Patole, S., Probiotics for prevention of necrotising entero-
colitis in preterm neonates with very low birth weight: A systematic review of ran-
domised controlled trials. Lancet , 369, 1614, 2007.
182. Szajewska, H. et al. Probiotics in gastrointestinal diseases in children: Hard and not-so-
hard evidence of efficacy. J Pediatr Gastroenterol Nutr ., 42, 454, 2006.
183. Kullen, M.J. and Bettler, J. The delivery of probiotics and prebiotics to infants. Curr
Pharm Des ., 11, 55, 2005.
184. Weizman, Z., Asli, G., and Alsheikh, A. Effect of a probiotic infant formula on infections
in child care centers: Comparison of two probiotic agents. Pediatrics, 115, 5, 2005.
185. Szajewska, H. and Mrukowicz, J.Z. Probiotics in the treatment and prevention of acute
infectious diarrhea in infants and children: A systematic review of published randomized,
double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr ., 33(S2), S17, 2001.
186. Mattar, A.F. et al. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2
cell-culture model. Pediatr Surg Int ., 18, 586, 2002.
187. Collado, M.C. et al. Protection mechanism of probiotic combination against human
pathogens: In vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr ., 15, 570,
2006.
188. Collado, M.C., Grzeskowiak, L., and Salminen, S. Probiotic strains and their combina-
tion inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol ., 55,
260, 2007.
189. Saavedra, J.M. et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophi-
lus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet ,
344, 1046, 1994.
190. Canani, R.B. et al. Probiotics for treatment of acute diarrhoea in children: Randomised
clinical trial of five different preparations. Br Med J ., 335, 340, 2007.
191. Szajewska, H., Skorka, A., and Dylag, M. Meta-analysis: Saccharomyces boulardii for
treating acute diarrhea in children. Aliment Pharmacol Ther., 25, 257, 2007.
192. Stratiki, Z. et al. The effect of a bifidobacter supplemented bovine milk on intestinal
permeability of preterm infants. Early Hum Dev ., 83, 575, 2007.
193. Saavedra, J.M. Use of probiotics in pediatrics: Rationale, mechanisms of action, and
practical aspects. Nutr Clin Pract ., 22, 351, 2007.
194. Kalliomaki, M. and Isolauri, E. Pandemic of atopic diseases—A lack of microbial expo-
sure in early infancy? Curr Drug Targets Infect Disord ., 2, 193, 2002.
195. Bjorksten, B. Evidence of probiotics in prevention of allergy and asthma. Curr Drug
Targets Inflamm Allergy, 4, 599, 2005.
196. Bjorksten, B. et al. The intestinal microflora in allergic Estonian and Swedish 2-year-old
children. Clin Exp Allergy , 29, 342, 1999.
197. Kalliomaki, M. et al. Probiotics in primary prevention of atopic disease: A randomised
placebo-controlled trial. Lancet , 357, 1076, 2001.
198. He, F. et al. Comparison of mucosal adhesion and species identification of bifidobacteria
isolated from healthy and allergic infants. FEMS Immunol Med Microbiol ., 30, 43, 2001.
199. Isolauri, E. et al. Probiotics in the management of atopic eczema. Clin Exp Allergy , 30,
1604, 2000.
200. Brouwer, M.L. et al. No effects of probiotics on atopic dermatitis in infancy: A random-
ized placebo-controlled trial. Clin Exp Allergy, 36, 899, 2006.